Worldwide Characterization of Severe Asthma Patients Eligible for both anti–IL-5 and anti-IgE Biologic Therapy: data from the International Severe Asthma Registry (ISAR)

Mohsen Sadatsafavi, Ruth B Murray, Nasloon Ali, Trung N Tran, David Price, ISAR FIRE Working Group

Research output: Contribution to journal › Abstract › peer-review

13 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Worldwide Characterization of Severe Asthma Patients Eligible for both anti–IL-5 and anti-IgE Biologic Therapy: data from the International Severe Asthma Registry (ISAR)'. Together they form a unique fingerprint.

Medicine & Life Sciences